Amanote Research
Register
Sign In
N-Glycosylation of Fc Regions to Improve Antibody Half-Life and Specificity
Science-Business eXchange
doi 10.1038/scibx.2013.503
Full Text
Open PDF
Abstract
Available in
full text
Date
May 1, 2013
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Rational Engineering of Fc/Fc Receptor Interactions to Improve Antibody Potency
Breast Cancer Research
Cancer Research
Oncology
A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-Yte, Has an Extended Half-Life in Healthy Adults
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Immunoglobulin G Fc N-Glycosylation in Guillain-Barré Syndrome Treated With Intravenous Immunoglobulin
Clinical and Experimental Immunology
Allergy
Immunology
Linker Engineering in Anti-Tag-72 Antibody Fragments Optimizes Biophysical Properties, Serum Half-Life, and High-Specificity Tumor Imaging
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Polyisoprenol Specificity in the Campylobacter Jejuni N-Linked Glycosylation Pathway
Modification of the Fc Region of a Human Anti-Oncostatin M Monoclonal Antibody for Higher Affinity to FcRn Receptor and Extension of Half-Life in Cynomolgus Monkeys
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Antigen Specificity Determines Anti-Red Blood Cell IgG-Fc Alloantibody Glycosylation and Thereby Severity of Haemolytic Disease of the Fetus and Newborn
British Journal of Haematology
Hematology
Fc or Not Fc; That Is the Question: Antibody Fc-Receptor Interactions Are Key to Universal Influenza Vaccine Design
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Fc-Glycosylation of IgG1 Is Modulated by B Cell Stimuli
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
